JIC
KIN

Johnson Investment Counsel’s Kindred Biosciences, Inc. KIN Stock Holding History

Johnson Investment Counsel’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-62,700
Closed -$326K – 567
2015
Q3 		$326K Hold
62,700
– – 0.01% 415
2015
Q2 		$427K Hold
62,700
– – 0.01% 369
2015
Q1 		$447K Sell
62,700
-391
-0.6% -$2.69K 0.02% 345
2014
Q4 		$470K Buy
+63,091
New +$535K 0.02% 329

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Johnson Investment Counsel's KIN Position: Q4 2015 in Review

Johnson Investment Counsel sold out of Kindred Biosciences, Inc. (KIN) in Q4 2015, closing a stake of 62,700 shares — an estimated $326K sold.

Johnson Investment Counsel first reported a position in KIN in Q4 2014 and held it in 4 quarters. The position peaked at $470K in Q4 2014. 50 funds tracked by Wall St. Rank hold KIN as of Q4 2015.

  • Johnson Investment Counsel reported no remaining Kindred Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Johnson Investment Counsel sold 62,700 Kindred Biosciences, Inc. shares in Q4 2015, an estimated $326K.
  • Johnson Investment Counsel first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 4 quarters.
  • Johnson Investment Counsel's Kindred Biosciences, Inc. position peaked at $470K in Q4 2014.
  • 50 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2015.

Based on Johnson Investment Counsel's 13F filing for Q4 2015, filed 12 Feb 2016.